Izotropic Corp logo

Izotropic Corp

C$ 0.83 (-1.19%) Dec 8
P/E:
At Loss
P/B:
0
Market Cap:
C$ 40.95M ($ 30.09M)
Enterprise V:
C$ 41.56M ($ 30.53M)
Volume:
13.50K
Avg Vol (2M):
39.44K
Also Trade In:
Volume:
13.50K
Market Cap C$:
40.95M
Market Cap $:
30.09M
PE Ratio:
At Loss
Avg Vol (2-Month):
39.44K
Enterprise Value C$:
41.56M
Enterprise Value $:
30.53M
PB Ratio:
0

Business Description

Description
Izotropic Corp is a research and development company specializing in cancer research and early detection for breast cancer. The Izotropic Breast CT Imaging System, IZOview produces high resolution breast images in 3D. The company has the worldwide license from the University of California, Davis to commercialize the technology. The license includes all intellectual property, trade secrets, patents and patent-pending applications that are the foundation of the company's breast CT imaging platform.
Name Current Vs Industry Vs History
Cash-To-Debt 0.7
Equity-to-Asset -0.3
Debt-to-Equity -3.78
Debt-to-EBITDA -0.32
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -108.5
3-Year EPS without NRI Growth Rate -95.7
3-Year FCF Growth Rate -77.1
Name Current Vs Industry Vs History
5-Day RSI 54.52
9-Day RSI 63.65
14-Day RSI 65.79
6-1 Month Momentum % 12.5
12-1 Month Momentum % -35.05

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.76
Quick Ratio 0.76
Cash Ratio 0.6

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -24.6
Name Current Vs Industry Vs History
ROE % -699.31
ROA % -253.83
ROIC % -735.8
ROC (Joel Greenblatt) % -12073.86
ROCE % -690.68

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -6.52
EV-to-EBITDA -6.52
EV-to-FCF -7.92
Earnings Yield (Greenblatt) % -15.35